Novel Doxorubicin Derivatives: Synthesis and Cytotoxicity Study in 2D and 3D in Vitro Models-Reference-Cited by-同舟云学术

Novel Doxorubicin Derivatives: Synthesis and Cytotoxicity Study in 2D and 3D in Vitro Models

Published:2017-12-31 Issue:4 Volume:7 Page:593-601
ISSN:2228-5881
Container-title:Advanced Pharmaceutical Bulletin
language:en
Short-container-title:Adv Pharm Bull

Author:

Akasov Roman,Drozdova Maria,Zaytseva-Zotova Daria,Leko Maria,Chelushkin Pavel,Marc Annie,Chevalot Isabelle,Burov Sergey,Klyachko Natalia,Vandamme Thierry,Markvicheva Elena

Publisher

Maad Rayan Publishing Company

Subject

General Pharmacology, Toxicology and Pharmaceutics,Pharmaceutical Science

Link

http://apb.tbzmed.ac.ir/pdf/apb-7-593.pdf

Reference40 articles.

1. Doxorubicin Induces Apoptosis in Normal and Tumor Cells via Distinctly Different Mechanisms

2. DNA Topoisomerases and Their Poisoning by Anticancer and Antibacterial Drugs

3. Doxorubicin, DNA torsion, and chromatin dynamics

4. Doxorubicin: an update on anticancer molecular action, toxicity and novel drug delivery systems

5. Multi-drug resistance in cancer chemotherapeutics: Mechanisms and lab approaches

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The fabrication method impacts biological properties of microfibrous three-dimensional in vitro cell culture scaffolds and their applications in drug screening;Materials Today Communications;2024-06

2. Topoisomerase II inhibitors design: Early studies and new perspectives;Bioorganic Chemistry;2023-07

3. Effective breast cancer therapy based on palmitic acid-loaded PLGA nanoparticles;Biomaterials Advances;2023-02

4. An in vivo zebrafish model reveals circulating tumor cell targeting capacity of serum albumin nanoparticles;Journal of Drug Delivery Science and Technology;2022-09

5. Thiosemicarbazones Can Act Synergistically with Anthracyclines to Downregulate CHEK1 Expression and Induce DNA Damage in Cell Lines Derived from Pediatric Solid Tumors;International Journal of Molecular Sciences;2022-08-01